Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation of ...

Denmark-based global pharma major, Novo Nordisk is now phasing out its Human Mixtard penfill by the year end. However Mixtard in India will continue to be available in vials. Along with it, other form ...

Brits with type 1 diabetes have told how they fear they could die 'within days' without access to life-saving insulin. Insulin – which helps to regulate blood sugar levels – is one of hundreds of ...

Tresiba (insulin degludec) is a brand-name drug that’s prescribed for diabetes. The medication is available as a liquid vial and a prefilled injection pen. The cost of Tresiba with and without ...

Tresiba (insulin degludec) is a prescription drug that’s used to manage high blood sugar in people with diabetes. Tresiba’s cost may depend on your dosage, your health insurance, and the pharmacy you ...

Tresiba (insulin degludec) and Lantus (insulin glargine) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat type 1 and type 2 diabetes in ...

Novo Nordisk (NVO) said new data from a phase 3a trial showed that more people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with its own once-daily therapy ...

If you have diabetes, your doctor might suggest Tresiba (insulin degludec) as a treatment option for you. Tresiba is a prescription medication. It’s used long term to manage blood sugar levels in ...

(RTTNews) - Danish pharmaceutical company Novo Nordisk A/S is recalling 1,468 product samples of Levemir, Tresiba, Fiasp, Novolog and Xultophy to the consumer level, due to improper storage ...